4.5 Article

Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome

期刊

NEUROBIOLOGY OF AGING
卷 35, 期 6, 页码 -

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2013.12.022

关键词

Down syndrome; BACE2; Alzheimer's disease; rs2252576

资金

  1. National Institute for Health Research Mental Health Biomedical Research Centre at South London
  2. Maudsley National Health Service Foundation Trust
  3. Medical Research Council
  4. Alzheimer's Society fellowship
  5. Henry Smith Charity [112]
  6. King's College London
  7. Wellcome Trust Strategic Grant Award [The London Down Syndrome (LonDownS) Consortium]
  8. MRC [G0902227, G0701075, MR/K013041/1] Funding Source: UKRI
  9. Alzheimers Research UK [ARUK-PG2014-1] Funding Source: researchfish
  10. Medical Research Council [MR/K013041/1, G0902227, MR/L501517/1, G0701075, MR/L010305/1] Funding Source: researchfish

向作者/读者索取更多资源

It is known that Alzheimer's disease (AD) presents at an early age in people with Down syndrome (DS). The trisomy 21 in DS provides an opportunity to study the effect of duplicated genes in AD. APP and BACE2 are 2 genes located in chromosome 21 and related to AD. We looked into our cohort of 67 DS cases with dementia for the effect of BACE2 variants in age of onset of dementia. Of the 83 single-nucleotide polymorphisms (SNPs), 6 were associated with age of onset and another 8 SNPs were borderline associated. Our finding also replicated a previous study showing association of rs2252576 with AD. (C) 2014 The Authors. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据